Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis

By sjmartinez • December 2, 2024

Cumpian NA, Choi G, Saab S. Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis. Dig Dis Sci. 2024 Dec 2. doi: 10.1007/s10620-024-08742-w. Epub ahead of print. PMID: 39621183.

Tags: ALP, Bezafibrate, Digestive Diseases, Elafibranor, General Internal Medicine, Harbor UCLA, OCA, PBC, Publications, Resident, second-line, Seladelpar, UDCA

Correction: Deep dive into water-aided colonoscopy – underwater techniques without a splash

Leung FW. Correction: Deep dive into water-aided colonoscopy - underwater techniques without a splash. Endoscopy. 2025 Jan 14. doi: 10.1055/a-2515-6349. Epub ahead of print. Erratum[...]

Oldest Reported Case of Solid Pseudopapillary Neoplasm: Diagnostic Challenge and Surgical Management

Bachu VS, Bahdi F, Makker J, Donahue TR, Kim S. Oldest Reported Case of Solid Pseudopapillary Neoplasm: Diagnostic Challenge and Surgical Management. Dig Dis Sci.[...]

Correction: Zhang et al. Hepatitis B Virus X Protein (HBx) Suppresses Transcription Factor EB (TFEB) Resulting in Stabilization of Integrin Beta 1 (ITGB1) in Hepatocellular Carcinoma Cells. Cancers 2021, 13, 1181

Zhang C, Yang H, Pan L, Zhao G, Zhang R, Zhang T, Xiao Z, Tong Y, Zhang Y, Hu R, Pandol SJ, Han YP. Correction:[...]